Information
-
Patent Application
-
20230293100
-
Publication Number
20230293100
-
Date Filed
June 04, 20213 years ago
-
Date Published
September 21, 2023a year ago
-
Inventors
-
Original Assignees
-
CPC
-
-
International Classifications
- A61B5/00
- A61B5/374
- A61B5/397
Abstract
There is described a computer-implemented method for measurement of a level of pain. The method comprises the steps of: — receiving measured data comprising electroencephalogram, EEG, data collected from one or more EEG electrodes; — extracting from the EEG data, a group 4 indicator corresponding to: — a power, power (ta), associated with a theta-alpha frequency band, ta, within a theta-alpha frequency range; and - determining, based on said group 4 indicator, a level of pain, LoP, which is a value indicative for the level of pain in the subject.
Claims
- 1. A computer-implemented method for measurement of a level of pain, the method comprising the steps of:
receiving measured data comprising electroencephalogram, EEG, data;extracting from the EEG data, a group 4 indicator corresponding to:
a power, power (ta), associated with a theta-alpha frequency band, ta, within a theta-alpha frequency range, the theta-alpha frequency band consisting of a combination of at least part of a theta frequency band and at least part of an alpha frequency band; anddetermining, based on said group 4 indicator, a level of pain, LoP, which is a value indicative of the level of pain in the subject.
- 2. The method according to claim 1, wherein the theta-alpha frequency band, ta, comprises one or more of the following:
a frequency band encompassing both theta and alpha brain waves;a frequency band extending from 6 Hz up to and including 12 Hz; and/ora bandwidth of at least 2 Hz and a frequency band comprising at least fast theta waves extending from 6 Hz up to and including 8 Hz, and/or
wherein the theta-alpha frequency range:
comprises a frequency range encompassing both theta and alpha brain waves; and/orextends from 4 Hz up to and including 12 Hz.
- 3. The method according to claim 1, comprising the step of:
extracting from the EEG data, a group 3 indicator corresponding to:
a mean signal peak-to-peak amplitude, MSPA; anddetermining the LoP based on the group 4 indicator and at least the group 3 indicator.
- 4. The method according to claim 1, comprising the step of:
receiving measured data comprising electromyography, EMG, data;extracting from the EMG data, a group 5 indicator corresponding to:
a mean signal peak-to-peak amplitude, EMG-MSPA; anddetermining the LoP based on the group 4 indicator and at least the group 5 indicator.
- 5. The method according to claim 4, comprising the steps of:
extracting from the EEG data, a group 3 indicator corresponding to:
a mean signal peak-to-peak amplitude, MSPA; anddetermining the LoP based on the group 4 indicator, the group 3 indicator, and the group 5 indicator.
- 6. The method according to claim 1, wherein the method comprises the step of:
receiving the measured data of the subject comprising the electroencephalogram, EEG, data collected from one or more of the following EEG electrodes:
a frontal (F) EEG electrode configured for collection of F-EEG electrode data from the scalp anatomical region corresponding to a frontal lobe of the subject,a parietal (P) EEG electrode configured for collection of P-EEG electrode data from the scalp anatomical region corresponding to a parietal lobe of the subject,a central (C) EEG electrode configured for collection of C-EEG electrode data from the scalp anatomical region corresponding to a precentral and postcentral gyrus of the subject.
- 7. The method according to claim 1, wherein the method comprises the steps of:
receiving reference data comprising measured data of a subject and/or a population correlated to at least one predetermined reference LoP;determining at least one correlation of at least one predetermined reference LoP and at least one group indicator extracted from the reference data; andscaling and/or indexing a subsequently measured LoP with respect to the at least one predetermined reference LoP by means of said at least one correlation, and optionally determining a level of pain index or LoPI therefrom.
- 8. A computer-implemented method for determining and/or monitoring a level of pain of a subject, comprising the method for measurement of a level of pain according to claim 1 applied on a subject by receiving the measured data of a subject.
- 9. A computer-implemented method for determining and/or monitoring and/or predicting and/or aggregating a level of pain in a subject before, during and/or after a treatment, wherein the method comprises the steps of:
measurement of the LoP according to claim 1, at at least two different points in time, preferably before, during and/or after the treatment;determining and/or monitoring and/or predicting and/or aggregating an evolution, preferably a treatment-induced evolution of the LoP, based on a comparison of at least two LoP measured at at least two different points in time; and/oraggregating a level of pain score or LoPS based on an aggregation of at least two LoP measured at at least two different points in time.
- 10. The method according to claim 9, wherein the method comprises the step of:
determining the treatment-induced evolution of the LoP, based on a comparison of the LoP measured during and/or after the treatment with the LoP measured before the treatment.
- 11. The method according to claim 9, wherein the treatment is a pain reducing treatment and the method comprises the step of:
determining and/or monitoring the efficacy of a pain treatment based on the treatment-induced evolution of the LoP.
- 12. The method according to claim 9, wherein the treatment is a pain treatment and the method comprises the step of:
optimizing and/or adapting a pain treatment based on the treatment-induced evolution of the LoP.
- 13. A computer-implemented method for determining a treatment and/or determining an adjustment to a treatment and/or determining an intensity of a treatment, wherein the method comprises the steps of:
measuring a LoP according to claim 1;determining a treatment and/or determining an adjustment to a treatment and/or determining an intensity of a treatment based on the measured LoP.
- 14. A system configured to measure a level of pain according to the method according to claim 1, the system comprising:
a monitoring apparatus configured to obtain measured data comprising electroencephalogram, EEG, data collected from one or more EEG electrodes;a controller module configured for:
receiving the measured data from the monitoring apparatus;extracting from the EEG data, a group 4 indicator corresponding to:
a power, power (ta), associated with a theta-alpha frequency band, ta, within a theta-alpha frequency range, the theta-alpha frequency band consisting of a combination of at least part of a theta frequency band and at least part of an alpha frequency band; anddetermining, based on said group 4 indicator, a level of pain, LoP, which is a value indicative for the level of pain in the subject.
- 15. A system according to claim 14, wherein the controller module is further configured for:
extracting from the EEG data, a group 3 indicator corresponding to:
a mean signal peak-to-peak amplitude, MSPA; anddetermining the LoP based on the group 4 indicator and at least the group 3 indicator.
- 16. A system according to claim 14, wherein the monitoring apparatus comprises, for obtaining measured data, one or more of:
one or more EEG electrodes configured for collection of electroencephalogram, EEG, data;one or more frontal (F) EEG electrodes configured for collection of F-EEG electrode data from the scalp anatomical region corresponding to a frontal lobe of the subject,one or more parietal (P) EEG electrodes configured for collection of P-EEG electrode data from the scalp anatomical region corresponding to a parietal lobe of the subject,one or more central (C) EEG electrodes configured for collection of C-EEG electrode data from the scalp anatomical region corresponding to a precentral and postcentral gyrus of the subject;optionally an EMG capturing unit;optionally a heart rate capturing unit;optionally a respiratory data capturing unit.
- 17. The system according to claim 14, further comprising a graphical user interface, GUI, configured to indicate numerically and/or graphically one or more of:
at least two LoP respectively measured at different points in time, preferably a historic, current and/or expected LoP.the evolution of and/or ratio between and/or aggregation of at least two LoP measured at different points in time;optionally, one or more components of the measured data, preferably one or more EEG data and optionally EMG data.
Priority Claims (1)
Number |
Date |
Country |
Kind |
20178463.4 |
Jun 2020 |
EP |
regional |
PCT Information
Filing Document |
Filing Date |
Country |
Kind |
PCT/EP2021/065061 |
6/4/2021 |
WO |
|